China Sky One Obtains CE Marks As It Sets Its Sights On International Markets
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - NASDAQ-listed China Sky One Medical has received European Union CE Mark status for its Myocardial Infarction and Urine Microalbumin diagnostic test kits. Meeting the EU health and safety standards of products ensures the company can expand to international markets, and it is now seeking partnerships with leading international distributors